Here's Why AnaptysBio Rose 22.1% in May

Shares of AnaptysBio (NASDAQ:ANAB) jumped over 22% last month, according to data provided by S&P Global Market Intelligence. The beaten-up biopharma stock trekked higher after the development-stage company delivered a slew of pipeline updates alongside first quarter 2020 operating results.